Product Information
DOXEPIN 5% CREAM is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $6.5788 per GM under NDC 00093960995. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Feb 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the doxepin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/g
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093960995
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215408FDA Approved
2/17/2023
TE Code
AB
On Market Since
2/17/2023
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 5% CREAM has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 31.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5788 per GM |
|---|---|
| All-time high | $9.5612 (May 15, 2024) |
| All-time low | $6.1513 (May 20, 2026) |
| 52-week high | $8.3765 |
| 52-week low | $6.1513 |
| Median price | $7.7269 |
| Average price | $7.7153 |
| Largest weekly change | -12.4% (Jun 19, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxepin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 5% CREAM, manufactured by Teva Pharmaceuticals USA Inc., is $6.5788 per GM (NDC 00093960995), effective Aug 19, 2026.
How has the price of DOXEPIN 5% CREAM changed over time?
Over the history we have for it, the NADAC for DOXEPIN 5% CREAM has declined 31.2%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DOXEPIN 5% CREAM?
Since Apr 17, 2024, the NADAC for DOXEPIN 5% CREAM has ranged from a low of $6.1513 (May 20, 2026) to a high of $9.5612 (May 15, 2024), with a median of $7.7269 per GM.
Are there cheaper alternatives to DOXEPIN 5% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN 5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXEPIN 5% CREAM?
DOXEPIN 5% CREAM (NDC 00093960995) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.